Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name ARRY-382
Trade Name
Synonyms
Drug Descriptions

ARRY-382 is a small molecule inhibitor of CSF1R, which potentially leads to decreased growth of CSF1R over expressing tumor cells (PMID: 29872489).

DrugClasses CSF1R Inhibitor 28
CAS Registry Number 1313407-95-2
NCIT ID C96227

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ARRY-382 ARRY-382 0 0
ARRY-382 + Pembrolizumab ARRY-382 Pembrolizumab 0 1


Additional content available in CKB BOOST